“Over time, we have been doing less radiation and less surgery to control local disease, mainly because our systemic therapies (endocrine therapy, aromatase inhibitors, and chemotherapy) are killing cancer cells and obviating the need for local therapy. This study is likely to be practice-changing,” said Kent Osborne, MD, Director of the Lester and Sue Smith Cancer Center at Baylor College of Medicine in Houston. ■

Disclosure: Dr. Osborne reported no potential conflicts of interest.